Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

37
Sell
  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: CNE100005D27
HKD
28.30
1.3 (4.81%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
78.00
-408.00
-682.00
-657.00
-535.00
-347.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-143.00
-10.00
111.00
-12.00
-32.00
89.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
209.00
-92.00
-357.00
-440.00
-253.00
-42.00
Cash Flow from Investing Activities
-148.00
-110.00
-178.00
-101.00
-211.00
-458.00
Cash Flow from Financing Activities
-78.00
-31.00
705.00
264.00
975.00
555.00
Net Cash Inflow / Outflow
-14.00
-230.00
186.00
-278.00
506.00
53.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
2.00
3.00
16.00
0.00
-4.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
78.8154837831716
691.94623516709
-613.00
-88.61%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-143.176095298075
-105.903732264301
-38.00
-35.19%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
209.359287092227
632.742192247138
-423.00
-66.91%
Cash Flow from Investing Activities
-148.66335216499
-774.965254787651
626.00
80.82%
Cash Flow from Financing Activities
-78.644176416056
60.245982032599
-138.00
-230.54%
Net Cash Inflow / Outflow
-14.9698785934581
-80.6467378531616
66.00
81.44%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
2.97836289535956
1.33034265475289
1.00
123.88%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 325.70% vs 74.04% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
209.36
-92.76
325.70%